Tactical Injector Kit - Ketamine
Award Notice Posted
- Solicitation number
- FA238424CB013
- Agency
-
Air Force Research Laboratory
Air Force Materiel Command, Department of Defense
- Awarded
- to RX Bandz, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- FA238424CB013 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- New Jersey, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Rx Bandz Inc. was awarded a $12,334,570 cost-plus-fixed-fee SBIR Phase III contract by the Department of the Air Force Materiel Command Research Laboratory for the development of an FDA-approved auto-injector device that can deliver a pre-measured dose of ketamine for mild sedation at point of injury in austere environments and/or during patient transport. The contract work will be performed in Fairfield, New Jersey, and is expected to be completed by October 1, 2029.
Notice text
Rx Bandz Inc., Austin, Texas, was awarded a $12,334,570 cost-plus-fixed-fee SBIR Phase III contract for tactical injection kit development. This contract provides for the development of an FDA-approved auto-injector device that can deliver a pre-measured dose of ketamine for mild sedation at point of injury in austere environments and/or during patient transport. Work will be performed in Fairfield, New Jersey, and is expected to be completed by Oct. 1, 2029.
Awarded contract FA238424CB013 to RX BANDZ, INC. for 12334570.00 on 2024-09-24.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity